Advertisement

Topics

Gilead macht Ernst - neuer Deal mit Hot-Stock Galapagos

03:45 EST 15 Dec 2017 | FinanzNachrichten
Related Biotechnology, Pharmaceutical and Healthcare News

Vor zwei Jahren hat Gilead einen Lizenzdeal mit Galapagos für den potenziellen Blockbuster Filgotinib geschlossen. Im Rahmen dieses Deals erwarben die Amerikaner 13,3 Prozent der Anteile, im Erfolg...

Original Article: Gilead macht Ernst - neuer Deal mit Hot-Stock Galapagos

NEXT ARTICLE

More From BioPortfolio on "Gilead macht Ernst - neuer Deal mit Hot-Stock Galapagos"

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
 

News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches


BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters at: priority@bioportfolio.com.
All rights reserved. All other trademarks recognized. Copyright © 1997-2017 BioPortfolio Limited. Site developed by Alacrify Ltd.